SCHEMBL9937238

SCHEMBL9937238

CCOC(=O)[C@H](O)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cc(C(=O)N(C)C)n[nH]1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930428 1.00 MME (0.67) MME
SCHEMBL9938842 0.91 MME (0.73) MME
SCHEMBL9929942 0.91 MME (0.73) MME
SCHEMBL9929631 0.91 MME (0.73) MME
SCHEMBL9929725 0.90 MME (0.78) MME
SCHEMBL18724675 0.90 MME (0.78) MME
SCHEMBL9930048 0.90 MME (0.75) MME
SCHEMBL9930168 0.90 MME (0.75) MME
SCHEMBL9929523 0.90 MME (0.75) MME
SCHEMBL9929522 0.90 MME (0.75) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 WO disclosed